anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Caribou Biosciences · pitchdeck

Caribou Biosciences | IPO Presentation Deck | 44 slides

44 pages · 4 arc beats · 3 loops

Pitchdeck Download JSON
Unlock

Caribou Biosciences | IPO Presentation Deck | 44 slides

Caribou Biosciences · 2021-07
arc beats above · slides in the middle · loops below · scroll → 3 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 32 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 1 slides 100% 1/1 slides 100% 1/1 slides · 6 hits
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides · 2 hits 100% 1/1 slides · 2 hits Solution 8 slides 100% 8/8 slides 100% 8/8 slides · 33 hits
— 0/8 slides
12.5% 1/8 slides 37.5% 3/8 slides 100% 8/8 slides · 9 hits 100% 8/8 slides · 9 hits Traction 22 slides 100% 22/22 slides 100% 22/22 slides · 83 hits
— 0/22 slides
50% 11/22 slides 31.8% 7/22 slides · 8 hits 100% 22/22 slides · 23 hits 18.2% 4/22 slides Competition 1 slides 100% 1/1 slides 100% 1/1 slides · 4 hits
— 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides · 2 hits
— 0/1 slides

Slide inventory

44
every slide · same image gating as the playbook
01
Slide 1
Includes date (July 2021) and company tagline.front_matter
Open slide detail
02
other
Open slide detail
03
summarize
Open slide detail
04
The slide is divided into two sections: a 2x2 grid for executive bios and a logo grid for investors.other
Open slide detail
05
transition
Open slide detail
06
The slide uses a structured list format to highlight four key pillars of the company's value proposition.summarize
Open slide detail
07
The slide uses a structured grid layout to categorize the company's technology platform and pipeline.present_solution
Open slide detailBeat · SolutionLoop · Golden Circle
08
The slide uses a visual comparison framework to contrast traditional autologous therapy with the company's allogeneic focus.compare_peers
Open slide detailBeat · SolutionLoop · Golden Circle
09
Uses a before-after-bridge style logic to frame the problem (efficacy challenge) and the company's solution (persistence).frame_problem
Open slide detailBeat · ProblemLoop · Golden Circle
10
The chart uses a conceptual line graph to show the impact of two specific genetic modifications on the duration of CAR-T cell activity.present_solution
Open slide detailBeat · SolutionLoop · Golden Circle
11
The slide uses a standard pharmaceutical pipeline visualization format.plan_implementation
Open slide detailBeat · SolutionLoop · Golden Circle
12
The slide serves as a section divider or introduction to the technology stack.present_solution
Open slide detailBeat · SolutionLoop · Golden Circle
13
present_solution
Open slide detailBeat · SolutionLoop · Golden Circle
14
The slide uses a process flow diagram to show the transition from raw materials to patient treatment.present_solution
Open slide detailBeat · SolutionLoop · Golden Circle
15
The charts show that chRDNA guides maintain high on-target editing while significantly reducing off-target editing compared to all-RNA guides.show_traction
Open slide detailBeat · TractionLoop · Zoom In
16
present_solution
Open slide detailBeat · TractionLoop · Zoom In
17
The chart is a flow cytometry plot showing insertion efficiency across two inserts.present_solution
Open slide detailBeat · TractionLoop · Zoom In
18
The slide uses a before/after diagram to explain the biological problem of translocation and a comparative box to show the performance improvement.present_solution
Open slide detailBeat · TractionLoop · Zoom In
19
transition
Open slide detailBeat · Traction
20
The slide uses a comparison table to demonstrate the competitive advantages of CB-010's specific gene-editing features.compare_peers
Open slide detailBeat · Traction
21
Uses a before-after comparison framework to explain the mechanism of action.present_solution
Open slide detailBeat · Traction
22
Includes bioluminescence imaging time-series and Kaplan-Meier survival curve.show_traction
Open slide detailBeat · Traction
23
Kaplan-Meier survival plots are standard for preclinical efficacy demonstration.show_traction
Open slide detailBeat · Traction
24
The slide outlines a standard 3+3 dose escalation clinical trial design.plan_implementation
Open slide detailBeat · Traction
25
The slide details the transition from healthy donor leukapheresis through genetic modification (using AAV, Cas9, and chRDNA) to final cryopreservation and treatpresent_solution
Open slide detailBeat · Traction
26
present_solution
Open slide detailBeat · Traction
27
The slide features a stylized microscopic image of cells, likely T-cells, as a background.transition
Open slide detailBeat · Traction
28
The slide uses a checkmark/cross comparison table to demonstrate competitive advantage.compare_peers
Open slide detailBeat · Traction
29
The slide uses a biological process diagram to illustrate the 'cloaking' mechanism.present_solution
Open slide detailBeat · Traction
30
The chart shows in vitro cytotoxicity measured 24 hours after co-incubation at various effector-to-target ratios.present_solution
Open slide detailBeat · Traction
31
Kaplan-Meier survival curves showing superior efficacy of CB-011.show_traction
Open slide detailBeat · Traction
32
present_solution
Open slide detailBeat · Traction
33
transition
Open slide detailBeat · Traction
34
The slide uses a checkmark vs X comparison table to establish competitive advantage.compare_peers
Open slide detailBeat · Traction
35
The chart is a Kaplan-Meier survival plot. The p-value < 0.0001 indicates statistical significance.show_traction
Open slide detailBeat · Traction
36
present_solution
Open slide detailBeat · Traction
37
The slide features a stylized illustration of a cell, likely an NK cell, interacting with other cells.transition
Open slide detail
38
The diagram shows a multi-step biological process: Gene editing, two stages of differentiation, and expansion.present_solution
Open slide detail
39
The slide presents four distinct assays validating the functional equivalence of iNK cells to primary NK cells.show_traction
Open slide detail
40
present_solution
Open slide detail
41
transition
Open slide detail
42
The slide uses a split-column layout to contrast past performance with future roadmap items.show_traction
Open slide detail
43
The slide uses a structured list format to highlight four key pillars of the company's value proposition.present_solution
Open slide detail
44
state_next_steps
Open slide detail